KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Shares Outstanding (Diluted Average) (2017)

BeOne Medicines (ONC) has disclosed Shares Outstanding (Diluted Average) for 8 consecutive years, with $113.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 7.75% to $113.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $113.4 million, a 7.75% increase, with the full-year FY2025 number at $113.4 million, up 7.75% from a year prior.
  • Shares Outstanding (Diluted Average) was $113.4 million for Q4 2025 at BeOne Medicines, down from $1.5 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.5 billion in Q3 2025 to a low of $102.8 million in Q2 2022.
  • A 4-year average of $447.1 million and a median of $108.9 million in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Biggest YoY gain for Shares Outstanding (Diluted Average) was 7.75% in 2025; the steepest drop was 7.75% in 2025.
  • BeOne Medicines' Shares Outstanding (Diluted Average) stood at $102.8 million in 2022, then rose by 1.64% to $104.5 million in 2023, then rose by 0.76% to $105.3 million in 2024, then grew by 7.75% to $113.4 million in 2025.
  • Per Business Quant, the three most recent readings for ONC's Shares Outstanding (Diluted Average) are $113.4 million (Q4 2025), $1.5 billion (Q3 2025), and $112.6 million (Q2 2025).